The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced Wednesday. It’s the first step in an anticipated global rollout that could protect millions – ...

"This really has the possibility of ending HIV transmission," said Greg Millett, public policy director at The Foundation for AIDS Research.